1亿美元融资助力:跨界布局数字资产与肿瘤疗法研发

Web3 DAO
Nov 11, 2025

澳大利亚生物制药公司Propanc获Hexstone Capital 1亿美元融资,跨界布局数字资产与肿瘤疗法研发总部位于澳大利亚的生物制药企业Propanc Biopharma(纳斯达克股票代码:PPCB)于周一正式宣布,已与专注于数字资产领域的家族办公室Hexstone Capital达成融资合作,成功获得高达1亿美元的私募融资额度。Hexstone Capital在加密货币市场活跃度显著,其...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10